Thursday, February 2, 2017

BRIEF-Trillium Therapeutics Inc intends to provide an update on ongoing TTI-621 trials

* Trillium Therapeutics Inc - intends to provide an update

on ongoing TTI-621 trials by year-end.

Read more

No comments:

Post a Comment